Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

NCT02341378 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Arthritis

Interventions

BIOLOGICAL: TissueGene-C(Low dose)
BIOLOGICAL: TissueGene-C(High dose)

Sponsor

Kolon Life Science